Yeganeh Reuven
Insider CIK 2044677 · PHGE Director, 10% owner · NUKK Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHGE BiomX Inc. | C Conversion deriv | 2026-03-17 | 2026-03-18 | 1,060 | — | $0 | 0 | SEC↗ |
| PHGE BiomX Inc. | S Sale | 2026-03-17 | 2026-03-18 | 530,000 | $5.00 | $2.65M | 0 | SEC↗ |
| PHGE BiomX Inc. | C Conversion | 2026-03-17 | 2026-03-18 | 530,000 | $2.00 | $1.06M | 530,000 | SEC↗ |
| PHGE BiomX Inc. | S Sale deriv | 2026-03-16 | 2026-03-18 | 1,300,000 | $5.00 | $6.50M | 2,000,000 | SEC↗ |
| PHGE BiomX Inc. | S Sale deriv | 2026-03-16 | 2026-03-18 | 2,000,000 | $5.24 | $10.48M | 1,700,000 | SEC↗ |
| PHGE BiomX Inc. | C Conversion deriv | 2026-03-16 | 2026-03-18 | 900 | — | $0 | 1,060 | SEC↗ |
| PHGE BiomX Inc. | S Sale deriv | 2026-03-16 | 2026-03-18 | 1,700,000 | $4.76 | $8.09M | 0 | SEC↗ |
| PHGE BiomX Inc. | C Conversion | 2026-03-16 | 2026-03-18 | 450,000 | $2.00 | $900.0K | 450,000 | SEC↗ |
| PHGE BiomX Inc. | S Sale | 2026-03-16 | 2026-03-18 | 450,000 | $5.00 | $2.25M | 0 | SEC↗ |
| PHGE BiomX Inc. | C Conversion deriv | 2026-03-13 | 2026-03-13 | 740 | — | $0 | 1,960 | SEC↗ |
| PHGE BiomX Inc. | C Conversion | 2026-03-13 | 2026-03-13 | 370,000 | $2.00 | $740.0K | 370,000 | SEC↗ |
| PHGE BiomX Inc. | S Sale | 2026-03-13 | 2026-03-13 | 370,000 | $5.00 | $1.85M | 0 | SEC↗ |
| PHGE BiomX Inc. | C Conversion deriv | 2026-03-12 | 2026-03-13 | 600 | — | $0 | 2,700 | SEC↗ |
| PHGE BiomX Inc. | S Sale | 2026-03-12 | 2026-03-13 | 300,000 | $5.00 | $1.50M | 0 | SEC↗ |
| PHGE BiomX Inc. | C Conversion | 2026-03-11 | 2026-03-13 | 300,000 | $2.00 | $600.0K | 30,000 | SEC↗ |
| NUKK Nukkleus Inc. | A Award | 2025-11-13 | 2025-11-20 | 10,000 | — | $0 | 20,000 | SEC↗ |
| NUKK Nukkleus Inc. | A Award | 2024-12-16 | 2024-12-20 | 10,000 | $1.39 | $13.9K | 10,000 | SEC↗ |